BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21448171)

  • 1. Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
    Flatmark K; Borgen E; Nesland JM; Rasmussen H; Johannessen HO; Bukholm I; Rosales R; Hårklau L; Jacobsen HJ; Sandstad B; Boye K; Fodstad Ø
    Br J Cancer; 2011 Apr; 104(9):1434-9. PubMed ID: 21448171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
    Wu P; Tang RN; Zou JH; Wang FC
    Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of disseminated tumour cells in non-small cell lung cancer.
    Rud AK; Borgen E; Mælandsmo GM; Flatmark K; Le H; Josefsen D; Solvoll I; Schirmer CB; Helland Å; Jørgensen L; Brustugun OT; Fodstad Ø; Boye K
    Br J Cancer; 2013 Sep; 109(5):1264-70. PubMed ID: 23942067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.
    Hartkopf AD; Wallwiener M; Fehm TN; Hahn M; Walter CB; Gruber I; Brucker SY; Taran FA
    Ann Oncol; 2015 Jun; 26(6):1155-1160. PubMed ID: 25791636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
    Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
    Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.
    Vogelaar FJ; Mesker WE; Rijken AM; van Pelt GW; van Leeuwen AM; Tanke HJ; Tollenaar RA; Liefers GJ
    BMC Cancer; 2010 Apr; 10():153. PubMed ID: 20406480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.
    Antolovic D; Galindo L; Carstens A; Rahbari N; Büchler MW; Weitz J; Koch M
    BMC Biotechnol; 2010 Apr; 10():35. PubMed ID: 20426872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
    Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
    Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
    Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
    Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
    Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.
    Tewes M; Kasimir-Bauer S; Welt A; Schuler M; Kimmig R; Aktas B
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):87-92. PubMed ID: 25108406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.